Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
Published Online: 9 JUL 2013
Assessed as up-to-date: 2 JUL 2013
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Lawrie TA, Bryant A, Cameron A, Gray E, Morrison J. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD006910. DOI: 10.1002/14651858.CD006910.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 9 JUL 2013
This article has been cited by:
- 1Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease, Molecular Pharmaceutics, 2015, 12, 11, 3973, , , , ,